Valuation: Consort Medical plc

Market Cap 502M 440M 406M 375M 706M 48.28B 720M 4.85B 1.9B 23.59B 1.89B 1.84B 81.44B P/E 2018
36.7x
P/E 2019 43.5x
Enterprise Value 599M 525M 485M 448M 843M 57.65B 859M 5.79B 2.27B 28.17B 2.25B 2.2B 97.25B EV / Sales 2018
2.2x
EV / Sales 2019 1.8x
Free-Float
-
Yield 2018
1.75%
Yield 2019 2.32%
Director TitleAgeSince
Director/Board Member 46 2023-01-31
Director/Board Member 52 2024-03-31
Director/Board Member 53 2024-03-31
Date Insider Type Main position Quantity % Market Cap.
20-02-05Sell 9,065 0.0184%
20-02-05Sell 211,474 0.4284%
20-02-05Sell 387 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+0.50% - - 628M
-3.42%-7.18%-32.62%-17.58% 160B
-5.11%-5.40%-11.62%-9.53% 107B
-1.26%-0.72%+1.76%+57.91% 59.56B
+0.35%-0.02%+43.33%+56.20% 52.51B
-2.07%-3.61%-14.93%-41.92% 42.39B
-4.73%-10.11% - - 34.31B
-2.92%+0.75%-13.14%-46.02% 29.46B
-0.57%+0.44%+59.32%-7.14% 25.41B
-3.83%-3.09%-7.56%-8.88% 21.15B
Average -2.36%-0.26%+3.07%-2.12% 53.28B
Weighted average by Cap. -2.97%-0.94%-7.57%-1.89%

Financials

2018 2019
Net sales 311M 272M 252M 232M 437M 29.92B 446M 3B 1.18B 14.62B 1.17B 1.14B 50.48B 305M 267M 247M 228M 429M 29.35B 438M 2.95B 1.15B 14.34B 1.15B 1.12B 49.51B
Net income 16.1M 14.1M 13.03M 12.03M 22.64M 1.55B 23.09M 156M 60.9M 757M 60.47M 59.13M 2.61B 10.5M 9.2M 8.5M 7.84M 14.76M 1.01B 15.06M 101M 39.72M 494M 39.44M 38.56M 1.7B
Net Debt 95.5M 83.63M 77.3M 71.34M 134M 9.19B 137M 922M 361M 4.49B 359M 351M 15.5B 97.4M 85.3M 78.84M 72.76M 137M 9.37B 140M 941M 368M 4.58B 366M 358M 15.8B
Logo Consort Medical plc
Consort Medical PLC is a United kingdom-based company that operates as a holding company. The Company wit its subsidiaries engaged in contract development and manufacturing organization (CDMO). The Company's services include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences.
Employees
-
  1. Stock Market
  2. Stocks
  3. CSRT Stock